Edge Medical Robotics

What Edge Medical Robotics does

Edge Medical Robotics (深圳市精锋医疗科技股份有限公司, Shenzhen Edge Medical Co., Ltd.) is a China-based surgical robotics company founded in 2017 and headquartered in Shenzhen's Longgang District. The company designs, develops, and manufactures endoscopic surgical robot systems for minimally invasive procedures, organized around six proprietary platform-type core technologies. Its commercial portfolio covers four product lines: the Edge® Multi-Port Laparoscopic Surgical Robot (suspended four-arm design with immersive 3D imaging for urology, gynecology, general surgery, and thoracic surgery), the Edge® Single-Port Laparoscopic Surgical Robot (single-arm, single-incision design for reduced trauma), the Edge® Bronchoscopic Surgical Robot (dual-arm, remotely controlled system with multi-modal navigation for lung-nodule biopsy and treatment), and the Edge® Cloud Remote Surgery System for tele-surgery. Edge is the first Chinese company to have all three surgical robot categories — multi-port, single-port, and bronchoscopic — approved for market in China, with cumulative global procedures exceeding 20,000 by May 2026.

The company generates revenue primarily through direct enterprise sales of surgical robot systems and related instruments, accessories, and consumables to hospitals and healthcare systems, supplemented by after-sales service, training, and support. Pricing is not publicly disclosed and is negotiated per system on an enterprise basis. Following its January 8, 2026 listing on the Hong Kong Stock Exchange under Chapter 18A (ticker 2675.HK) — which raised approximately HK$1.2 billion at an offer price of HK$43.24 per share and valued the company at HK$16,765 million — Edge is accelerating commercialization, manufacturing capacity buildout, and international expansion, with its first Philippines installation at Cardinal Santos Medical Center and first European clinical use of its single-port robot in 2025-2026.

The company was previously backed by six pre-IPO funding rounds totaling approximately RMB 2,050 million from investors including Boyu Capital, Temasek, OrbiMed, HSG, LYFE Capital, Greater Bay Area Homeland Development Fund, and Lenovo Star. The company is led by founder Jianchen Wang (Chairman & General Manager). Headcount remains modest at 11-50 employees, reflecting an organization that is still scaling commercial operations and international footprint post-IPO.

Name

Edge Medical Robotics

Legal name

深圳市精锋医疗科技股份有限公司

Website

https://edgemedicalrobotics.com

Company type

Public

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Edge Medical Robotics is a Shenzhen-based surgical robotics company that designs, develops, and sells endoscopic surgical robot systems — including multi-port, single-port, and bronchoscopic robots — to hospitals for minimally invasive procedures across multiple surgical specialties.

Ownership category

akta.pro rank

Product category

Surgical Robotics

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)

akta.pro secondary industries

Healthcare & Assistive Robotics (HDAAAIAC), Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Surgical robotics
• Medical devices
• Minimally invasive surgery
• Robotic surgery systems
• Laparoscopic robots

Headquarters

HQ city

Shenzhen

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Surgical Robot Systems Sales: Sale of multi-port, single-port, and bronchoscopic surgical robot systems to hospitals and healthcare providers.
2. Surgical Instruments and Accessories: Recurring sales of proprietary instruments, accessories, and consumables used during robotic surgical procedures.
3. Service and Support: After-sales service, training, and support for installed robotic surgical systems.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Edge Medical Robotics designs, develops, and manufactures endoscopic surgical robot systems for hospitals and healthcare providers. Built on six proprietary platform-type core technologies, the product portfolio includes the Edge® Multi-Port Laparoscopic Surgical Robot, Edge® Single-Port Laparoscopic Surgical Robot, Edge® Bronchoscopy Robot, and the Edge® Cloud Remote Surgery System, all approved for market in China. The company also generates recurring revenue through proprietary surgical instruments, accessories, and after-sales service and training.

Product overview

Edge Medical Robotics (深圳市精锋医疗科技股份有限公司) is a China-based surgical robotics company offering a comprehensive product portfolio built on six proprietary platform technologies. The company is China's first to have all three product categories—multi-port laparoscopic surgical robot, single-port laparoscopic surgical robot, and bronchoscopy robot—approved for market. These products share a common technology foundation but target different surgical approaches: multi-port for full-spectrum multi-quadrant surgery, single-port for minimized-incision procedures, and bronchoscopy for lung nodule diagnosis and treatment. The company also offers a cloud-based remote surgery system to extend surgical capabilities geographically.

Differentiator

Problem solved

Functional benefit

Brands

• 精锋®多孔腔镜手术机器人: Multi-port laparoscopic surgical robot with suspended four-arm design, immersive low-latency 3D imaging system, intuitive operation, and rotatable surgical instruments for urology, gynecology, general surgery, and thoracic surgery.
• 精锋®单孔腔镜手术机器人
• 精锋®支气管镜手术机器人
• 精锋®云远程手术系统

Products and services

• Edge® Multi-Port Laparoscopic Surgical Robot (精锋®多孔腔镜手术机器人) Suspension-type four-arm robotic system with immersive low-latency 3D imaging, intuitive flexible operation, and multi-joint rotatable surgical instruments, applicable to urology, gynecology, general surgery, and thoracic surgery. Sold to hospitals and healthcare providers.
• Edge® Single-Port Laparoscopic Surgical Robot (精锋®单孔腔镜手术机器人) Single-arm robotic system that enters through a single small incision (e.g., umbilicus), enabling flexible surgical operation in narrow channels and significantly reducing wound area. Approved for four core departments. Sold to hospitals and healthcare providers.
• Edge® Bronchoscopy Robot (精锋®支气管镜手术机器人) Dual-arm robotic system controlled via remote handle, combining multimodal navigation technology to guide ultra-thin flexible catheters through bronchi to reach pulmonary nodules for precise biopsy and treatment. Sold to hospitals and healthcare providers.
• Edge® Cloud Remote Surgery System (精锋®云远程手术系统) Cloud-based remote surgical system enabling surgeons to perform procedures remotely using the company's surgical robotics platform; supports telemedicine and remote surgical guidance. Sold to hospitals and healthcare providers.

Quantifiable outcome

• Over 20,000 global robotic surgeries performed by May 2026
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Clifford ChancecoreImplementation/ SI/ Consulting PartnerGlobal law firm Clifford Chance acted as legal adviser for Edge Medical's Chapter 18A IPO and listing on the Hong Kong Stock Exchange, which raised approximately HK$1.2 billion.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Intuitive Surgical: Global leader in surgical robotics with the da Vinci multi-port system, da Vinci SP (single-port), and Ion robotic bronchoscopy platform — directly comparable across all three of Edge Medical's product categories. Edge Medical is explicitly positioning against Intuitive's installed base and category dominance in both China and international markets.
• Shanghai MicroPort MedBot: Chinese surgical robotics company and the most direct domestic competitor to Edge Medical, with the Toumai laparoscopic surgical robot. Both companies compete for the same Chinese hospital customers, regulatory approvals, and government support under 'Made in China 2025' localization policies.
• CMR Surgical: UK-based surgical robotics company with the Versius system, a modular multi-port laparoscopic robot targeting similar use cases in urology, gynecology, and general surgery. Comparable mid-stage competitor focused on a single-portfolio approach versus Edge Medical's multi-platform strategy.

Broad incumbents

• Medtronic: Global medical device giant with the Hugo robotic-assisted surgery system entering the surgical robotics market. As a broad incumbent, Medtronic offers hospital customers an integrated robotics-plus-full-portfolio solution that Edge Medical cannot match in breadth, though Hugo is less established in surgical robotics.
• Stryker: Established medical device incumbent with the Mako robotic system primarily used in orthopedic surgery. While Mako competes in a different surgical subsegment, Stryker's hospital relationships, capital, and global commercialization infrastructure make it a comparable enterprise competitor for large hospital capital equipment deals.
• Johnson & Johnson: Healthcare conglomerate with the Ottava general surgery robot in development and the Monarch robotic bronchoscopy platform (via Auris Health). Directly comparable in bronchoscopy, where Monarch competes against Edge Medical's bronchoscope robot, and a formidable long-term competitor in laparoscopic surgery.

Emerging players

• Noah Medical: Emerging robotic bronchoscopy company with the Galaxy system, directly competing against Edge Medical's bronchoscope robot in lung nodule diagnosis. Comparable as a focused, well-funded emerging player in a single surgical robotics subsegment where Edge Medical also competes.
• Asensus Surgical: Emerging surgical robotics company with the Senhance system, focused on laparoscopic procedures. Comparable as an early-stage publicly-traded surgical robotics peer with a smaller installed base, providing a useful comparison for capital allocation and commercialization pace at Edge Medical's stage.
• Vicarious Surgical: Emerging single-port surgical robotics company developing a decoupled dual-arm system for abdominal surgery. Comparable as a focused single-port robotics competitor, though Vicarious is at an earlier development stage than Edge Medical's commercially launched single-port system.
• Moon Surgical: European-based emerging surgical robotics company with the Maestro system, designed as an accessible laparoscopic surgical assistance platform. Comparable as an emerging peer focused on simplifying robotic surgery adoption — addressing similar hospital pain points around cost and ergonomics that Edge Medical targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds5 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Edge Medical Robotics